• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A comparative case study of bowel cancer screening in the UK and Australia: evidence lost in translation?英国和澳大利亚的结直肠癌筛查对比案例研究:信息在转化中丢失了吗?
J Med Screen. 2011;18(4):193-203. doi: 10.1258/jms.2011.011066. Epub 2011 Nov 21.
2
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.用于结直肠癌筛查的粪便潜血试验:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
3
Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.英国皇家空军中结直肠癌筛查的选项:一项成本效益评估。
J R Army Med Corps. 1995 Oct;141(3):142-50. doi: 10.1136/jramc-141-03-04.
4
Colorectal cancer: implications of mass screening for public health.结直肠癌:大规模筛查对公共卫生的影响
Med J Aust. 1990 Jul 16;153(2):81-2, 85-8. doi: 10.5694/j.1326-5377.1990.tb136797.x.
5
Planning for a possible national colorectal cancer screening programme.规划一项可能的全国性结直肠癌筛查计划。
J Med Screen. 1998;5(4):187-94. doi: 10.1136/jms.5.4.187.
6
The National Health Service Bowel Cancer Screening Program: the early years.英国国家医疗服务体系肠癌筛查计划:早期阶段。
Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5):421-37. doi: 10.1586/17474124.2013.811045.
7
The impact of CT colonography for colorectal cancer screening on the UK NHS: costs, healthcare resources and health outcomes.CT 结肠成像用于结直肠癌筛查对英国国民保健制度的影响:成本、医疗资源和健康结果。
Appl Health Econ Health Policy. 2011;9(1):51-64. doi: 10.2165/11588110-000000000-00000.
8
Outcomes of faecal occult blood tests requested outside the UK National Bowel Cancer Screening Programme.英国国家肠癌筛查计划之外要求进行粪便潜血试验的结果。
J Clin Pathol. 2013 Apr;66(4):330-4. doi: 10.1136/jclinpath-2011-200406. Epub 2013 Jan 2.
9
Cost-effectiveness of colonoscopy in screening for colorectal cancer.结肠镜检查在结直肠癌筛查中的成本效益
Ann Intern Med. 2000 Oct 17;133(8):573-84. doi: 10.7326/0003-4819-133-8-200010170-00007.
10
The NHS Bowel Cancer Screening Programme--a realistic approach with additional benefits.英国国民医疗服务体系肠癌筛查计划——一种具有额外益处的务实方法。
Colorectal Dis. 2008 Sep;10(7):708-14. doi: 10.1111/j.1463-1318.2007.01396.x. Epub 2007 Oct 23.

引用本文的文献

1
Comparing 3 values clarification methods for colorectal cancer screening decision-making: a randomized trial in the US and Australia.比较三种用于结直肠癌筛查决策的价值澄清方法:在美国和澳大利亚进行的一项随机试验。
J Gen Intern Med. 2014 Mar;29(3):507-13. doi: 10.1007/s11606-013-2701-0. Epub 2013 Nov 23.
2
Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death.粪便血红蛋白浓度对结直肠癌死亡率和全因死亡的影响。
BMJ Open. 2013 Nov 7;3(11):e003740. doi: 10.1136/bmjopen-2013-003740.
3
Colorectal cancer screening: why immunochemical fecal occult blood tests may be the best option.结直肠癌筛查:为何免疫化学粪便潜血试验可能是最佳选择。
BMC Gastroenterol. 2012 Dec 29;12:183. doi: 10.1186/1471-230X-12-183.
4
Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.筛查肾移植受者的结直肠癌和高级结直肠肿瘤:粪便免疫化学检测血红蛋白和结肠镜检查的横断面患病率和诊断准确性研究。
BMJ. 2012 Jul 25;345:e4657. doi: 10.1136/bmj.e4657.

本文引用的文献

1
Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia.澳大利亚全面实施两年一次粪便潜血试验筛查结直肠癌项目的成本及成本效益。
Med J Aust. 2011 Feb 21;194(4):180-5. doi: 10.5694/j.1326-5377.2011.tb03766.x.
2
Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.粪便标志物在结直肠肿瘤筛查中的应用:欧洲肿瘤标志物专家组立场文件。
Int J Cancer. 2011 Jan 1;128(1):3-11. doi: 10.1002/ijc.25654.
3
Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice?澳大利亚 15 年的结直肠癌筛查政策:将证据付诸实践?
Med J Aust. 2010 Jul 5;193(1):37-42. doi: 10.5694/j.1326-5377.2010.tb03739.x.
4
Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme.临界值决定了在结直肠癌筛查项目中半定量免疫化学粪便潜血试验的性能。
Br J Cancer. 2009 Oct 20;101(8):1274-81. doi: 10.1038/sj.bjc.6605326. Epub 2009 Sep 15.
5
Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.结直肠癌筛查:基于愈创木脂和免疫化学粪便潜血检测与柔性乙状结肠镜检查的随机试验比较。
Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089.
6
Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.免疫化学粪便潜血试验和灵敏愈创木脂试验检测重大结直肠肿瘤相对效率的结肠镜定量评估
Aliment Pharmacol Ther. 2009 Feb 15;29(4):450-7. doi: 10.1111/j.1365-2036.2008.03898.x. Epub 2008 Nov 17.
7
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.结直肠癌筛查:美国预防服务工作组建议声明
Ann Intern Med. 2008 Nov 4;149(9):627-37. doi: 10.7326/0003-4819-149-9-200811040-00243. Epub 2008 Oct 6.
8
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.结直肠癌筛查:17个国家35项举措的比较
Int J Cancer. 2008 Mar 15;122(6):1357-67. doi: 10.1002/ijc.23273.
9
Screening for colorectal cancer using the faecal occult blood test, Hemoccult.使用便潜血试验(Hemoccult)筛查结直肠癌。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001216. doi: 10.1002/14651858.CD001216.pub2.
10
Option appraisal of population-based colorectal cancer screening programmes in England.英格兰基于人群的结直肠癌筛查项目的方案评估
Gut. 2007 May;56(5):677-84. doi: 10.1136/gut.2006.095109. Epub 2006 Dec 1.

英国和澳大利亚的结直肠癌筛查对比案例研究:信息在转化中丢失了吗?

A comparative case study of bowel cancer screening in the UK and Australia: evidence lost in translation?

机构信息

Health Policy, Screening and Test Evaluation Program, Sydney School of Public Health, Edward Ford Building, A27, University of Sydney, NSW 2006, Australia.

出版信息

J Med Screen. 2011;18(4):193-203. doi: 10.1258/jms.2011.011066. Epub 2011 Nov 21.

DOI:10.1258/jms.2011.011066
PMID:22106435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3466604/
Abstract

OBJECTIVES

(i) To document the current state of the English, Scottish, Welsh, Northern Irish and Australian bowel cancer screening programmes, according to seven key characteristics, and (ii) to explore the policy trade-offs resulting from inadequate funding.

SETTING

United Kingdom and Australia.

METHODS

A comparative case study design using document and key informant interview analysis. Data were collated for each national jurisdiction on seven key programme characteristics: screening frequency, population coverage, quality of test, programme model, quality of follow-up, quality of colonoscopy and quality of data collection. A list of optimal features for each of the seven characteristics was compiled, based on the FOBT screening literature and our detailed examination of each programme.

RESULTS

Each country made different implementation choices or trade-offs intended to conserve costs and/or manage limited and expensive resources. The overall outcome of these trade-offs was probable lower programme effectiveness as a result of compromises such as reduced screening frequency, restricted target age range, the use of less accurate tests, the deliberate setting of low programme positivity rates or increased inconvenience to participants from re-testing.

CONCLUSIONS

Insufficient funding has forced programme administrators to make trade-offs that may undermine the potential net population benefits achieved in randomized controlled trials. Such policy compromise contravenes the principle of evidence-based practice which is dependent on adequate funding being made available.

摘要

目的

(i) 根据七个关键特征,记录英国、苏格兰、威尔士、北爱尔兰和澳大利亚的结肠癌筛查计划的现状;(ii) 探讨由于资金不足而导致的政策权衡。

背景

英国和澳大利亚。

方法

采用文献分析和关键知情人访谈的比较案例研究设计。针对每个国家的七个关键计划特征,收集了数据:筛查频率、人口覆盖范围、检测质量、计划模式、随访质量、结肠镜检查质量和数据收集质量。根据 FOBT 筛查文献以及我们对每个计划的详细检查,为七个特征中的每一个都编制了最佳特征的清单。

结果

每个国家都做出了不同的实施选择或权衡取舍,以节省成本和/或管理有限和昂贵的资源。这些权衡取舍的总体结果可能是由于妥协而导致计划效果降低,例如降低筛查频率、限制目标年龄范围、使用不太准确的检测、故意设定低计划阳性率或增加参与者重新检测的不便。

结论

资金不足迫使计划管理者做出可能破坏随机对照试验中实现的潜在净人群效益的权衡取舍。这种政策妥协违反了基于证据的实践原则,该原则取决于是否有足够的资金。